TY - CHAP M1 - Book, Section TI - Sickle Cell Anemia & Related Syndromes A1 - Damon, Lloyd E. A1 - Andreadis, Charalambos Babis A2 - Papadakis, Maxine A. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. A2 - Gandhi, Monica Y1 - 2025 N1 - T2 - Current Medical Diagnosis & Treatment 2025 AB - Key Clinical Updates in Sickle Cell Anemia & Related SyndromesTwo genetically engineered stem cell products used with autologous transplantation, lovotibeglogene autotemcel and exagamglogene autotemcel, are approved in the United States for patients 12 years or older with severe disease and offer the potential for long-term disease control.Kanter J et al. N Engl J Med. [PMID: 34898139] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/11/04 UR - accessmedicine.mhmedical.com/content.aspx?aid=1209225383 ER -